← back to search

Yee‐Sin Leo

National University of Singapore · SG
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, Viral Infections and Vectors, and COVID-19 Clinical Research Studies.
h-index
85
citations
33,224
works
488
NIH funding
primary concept
Medicine
email

Recent publications

A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission
Nature Medicine 2025cited by 7position: middledoi
Respiratory syncytial virus hospitalization costs, rates, and seasonality in Asia: a systematic review and meta-analysis
EClinicalMedicine 2025cited by 7position: middledoi
Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore
Clinical Infectious Diseases 2022cited by 85position: middledoi
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore
JAMA Network Open 2022cited by 75position: middledoi
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Nature Communications 2022cited by 56position: middledoi
Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
EMBO Molecular Medicine 2022cited by 38position: middledoi
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
Frontiers in Immunology 2022cited by 24position: middledoi
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Clinical Infectious Diseases 2021cited by 421position: middledoi
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
The Lancet Microbe 2021cited by 401position: middledoi
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Clinical Microbiology and Infection 2021cited by 305position: middledoi
A living WHO guideline on drugs to prevent covid-19
BMJ 2021cited by 150position: middledoi
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
Open Forum Infectious Diseases 2021cited by 128position: middledoi
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
Cell Reports Medicine 2021cited by 53position: middledoi
High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identification
Nucleic Acids Research 2021cited by 51position: middledoi
Differentiating coronavirus disease 2019 (COVID-19) from influenza and dengue
Scientific Reports 2021cited by 38position: middledoi
Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance data
Antimicrobial Resistance and Infection Control 2021cited by 38position: middledoi
Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
The Lancet Regional Health - Western Pacific 2021cited by 24position: middledoi
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
EBioMedicine 2021cited by 20position: middledoi
A living WHO guideline on drugs for covid-19 (2020-2023)
BMJ 2020cited by 1,085position: middledoi
Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients
Nature Communications 2020cited by 947position: middledoi
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
The Lancet 2020cited by 710position: middledoi
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
The Lancet 2020cited by 491position: middledoi
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
Nature Communications 2020cited by 438position: middledoi
COVID-19 in Singapore—Current Experience
JAMA 2020cited by 426position: middledoi
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2
mBio 2020cited by 320position: middledoi
Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
Clinical Infectious Diseases 2020cited by 295position: middledoi
Connecting clusters of COVID-19: an epidemiological and serological investigation
The Lancet Infectious Diseases 2020cited by 294position: middledoi
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study
The Lancet Infectious Diseases 2020cited by 238position: middledoi
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Clinical Infectious Diseases 2020cited by 229position: middledoi
Epidemiological and Clinical Predictors of COVID-19
Clinical Infectious Diseases 2020cited by 226position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David Chien Lye · Agency for Science, Technology and Research35 papers (2012–2025)Lisa F. P. Ng · Agency for Science, Technology and Research16 papers (2012–2021)Barnaby Edward Young · National Centre for Infectious Diseases16 papers (2020–2021)Mark Chen · Cleveland Clinic13 papers (2012–2021) · 12 papers (2013–2021)Laurent Rénia · Hospital Universitario de Gran Canaria Doctor Negrín11 papers (2012–2021) · 9 papers (2012–2016)Angela Chow · National University of Singapore9 papers (2012–2018)Junxiong Pang · Duke-NUS Medical School9 papers (2012–2020)Vernon J. Lee · Agency for Science, Technology and Research8 papers (2012–2022) · 7 papers (2012–2018)Po Ying Chia · Agency for Science, Technology and Research7 papers (2018–2025)Seow Yen Tan · SingHealth7 papers (2020–2021)Bernett Lee · Nanyang Technological University7 papers (2016–2021)Shawn Vasoo · National Centre for Infectious Diseases7 papers (2019–2021)Oon Tek Ng · Nanyang Technological University6 papers (2012–2022)Jenny G. Low · Duke-NUS Medical School6 papers (2013–2021)Lin‐Fa Wang · Ministry of Industry and Information Technology6 papers (2020–2021)Shirin Kalimuddin · Singapore General Hospital6 papers (2019–2021)Siti Naqiah Amrun · Agency for Science, Technology and Research6 papers (2018–2021)